Adverse Events Linked to Better Survival With ICIs in Melanoma Adverse Events Linked to Better Survival With ICIs in Melanoma

With immune checkpoint inhibitors (ICIs), survival is improved even among patients who develop higher-grade immune adverse events leading to hospitalization, a new study reveals.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news